BIOCRYST PHARMACEUTICALS INC Quarterly Weighted Average Number of Shares Outstanding, Basic from Q2 2014 to Q2 2024

Taxonomy & unit
us-gaap: shares
Description
Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.
Summary
Biocryst Pharmaceuticals Inc quarterly/annual Weighted Average Number of Shares Outstanding, Basic history and growth rate from Q2 2014 to Q2 2024.
  • Biocryst Pharmaceuticals Inc Weighted Average Number of Shares Outstanding, Basic for the quarter ending June 30, 2024 was 206M shares, a 9.15% increase year-over-year.
  • Biocryst Pharmaceuticals Inc annual Weighted Average Number of Shares Outstanding, Basic for 2023 was 192M shares, a 3.38% increase from 2022.
  • Biocryst Pharmaceuticals Inc annual Weighted Average Number of Shares Outstanding, Basic for 2022 was 186M shares, a 3.79% increase from 2021.
  • Biocryst Pharmaceuticals Inc annual Weighted Average Number of Shares Outstanding, Basic for 2021 was 179M shares, a 7.08% increase from 2020.
Weighted Average Number of Shares Outstanding, Basic, Quarterly (shares)
Weighted Average Number of Shares Outstanding, Basic, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2024 206M +17.3M +9.15% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-06
Q1 2024 206M +17.6M +9.31% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-07
Q4 2023 192M +6.29M +3.38% Oct 1, 2023 Dec 31, 2023 10-K 2024-02-27
Q3 2023 190M +3.46M +1.86% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-08
Q2 2023 189M +3.51M +1.89% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-06
Q1 2023 189M +3.61M +1.95% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-07
Q4 2022 186M Oct 1, 2022 Dec 31, 2022 10-K 2024-02-27
Q3 2022 186M +7.07M +3.95% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-08
Q2 2022 186M +7.48M +4.2% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-07
Q1 2022 185M Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-08
Q3 2021 179M Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-04
Q2 2021 178M Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-05
Q2 2016 73.7M +1.05M +1.45% Apr 1, 2016 Jun 30, 2016 10-Q 2016-08-08
Q2 2015 72.6M +9M +14.1% Apr 1, 2015 Jun 30, 2015 10-Q 2016-08-08
Q2 2014 63.6M Apr 1, 2014 Jun 30, 2014 10-Q 2015-08-07
* An asterisk sign (*) next to the value indicates that the value is likely invalid.